NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
Back to search
Official data from USPTO
MAGNAWAVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
05/07/2024
Trademark type
Word
Nice classes
44
Filing date
01/27/2021
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
05/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/23/2019
First use in commerce
12/23/2019
Drawing code
4
Owner type
03
Owner location
Louisville, KY
Examiner
SHANOSKI,JOANNA MARIE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Magna Wave, Inc.
Representatives
LAURA H. PULLIAM STOLL KEENON OGDEN PLLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Veterinary servicesinflammation reductionpain reliefimproved blood oxygenation and blood flow; Health care servicesinflammation reductionpain reliefimproved blood oxygenation and blood flow
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/02/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/22/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/21/2024
EX2G
SOU EXTENSION 2 GRANTED
03/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/21/2024
IUAF
USE AMENDMENT FILED
02/28/2024
EXT2
SOU EXTENSION 2 FILED
02/28/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/25/2023
EX1G
SOU EXTENSION 1 GRANTED
08/23/2023
EXT1
SOU EXTENSION 1 FILED
08/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/23/2023
DOCK
ASSIGNED TO EXAMINER
07/19/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
EXPT
EXPARTE APPEAL TERMINATED
11/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2022
ALIE
ASSIGNED TO LIE
11/15/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/06/2022
EXPI
EX PARTE APPEAL-INSTITUTED
10/06/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/06/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
10/06/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/08/2022
GNFR
FINAL REFUSAL E-MAILED
04/08/2022
CNFR
FINAL REFUSAL WRITTEN
04/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/17/2021
GNRT
NON-FINAL ACTION E-MAILED
08/17/2021
CNRT
NON-FINAL ACTION WRITTEN
08/17/2021
DOCK
ASSIGNED TO EXAMINER
08/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/11/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/11/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/29/2021
NWAP
NEW APPLICATION ENTERED
01/30/2021
Continuous trademark protection
Get notified about every new filing that threatens MAGNAWAVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.